Skip to main content

Gordon Ralph Corey

Gary Hock Distinguished Professor Emeritus in Global Health, in the School of Medicine
Medicine, Infectious Diseases
310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708

Overview


My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Current Appointments & Affiliations


Gary Hock Distinguished Professor Emeritus in Global Health, in the School of Medicine · 2020 - Present Medicine, Infectious Diseases, Medicine
Professor Emeritus of Medicine · 2020 - Present Medicine, Infectious Diseases, Medicine
Vice-Chair for Education and Global Health in the Department of Medicine · 2011 - Present Medicine, Infectious Diseases, Medicine

In the News


Published June 5, 2014
Single dose of antibiotic found effective in quelling MRSA
Published June 5, 2014
New single-dose antibiotic may help battle superbug MRSA
Published June 4, 2014
One and Done: New Antibiotic Could Provide Single-Dose Option

View All News

Recent Publications


A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.

Journal Article Clin Ther · June 2019 PURPOSE: This analysis evaluates the efficacy and safety of iclaprim versus vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in patients who were intravenous drug users (IVDUs). METHODS: A total of 621 patients w ... Full text Link to item Cite

Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults.

Journal Article Clin Infect Dis · February 15, 2019 Clinical trials for Staphylococcus aureus bloodstream infections (SAB) are broadly grouped into 2 categories: registrational trials intended to support regulatory approval of antibiotics for the treatment of SAB and strategy trials intended to inform clini ... Full text Link to item Cite

Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe.

Journal Article Diagn Microbiol Infect Dis · February 2019 Iclaprim is a diaminopyrimidine, which inhibits bacterial dihydrofolate reductase, and surveillance data prior to 2006 suggested that iclaprim was active against Gram-positive pathogens including emerging drug-resistant pathogens. In an era of increasing a ... Full text Link to item Cite
View All Publications

Recent Grants


Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria

ResearchAdvisor · Awarded by National Institutes of Health · 2011 - 2022

Optimizing treatment for E. faecalis infective endocarditis: ampicillin plus ceftriaxone versus ampicillin plus gentamicin

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2019

Bacteremia Modification 14

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2009 - 2017

View All Grants

Education, Training & Certifications


Baylor University · 1973 M.D.